EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting the 8-oxodG Base Excision Repair Pathway for Cancer Therapy

Anna Piscone, Francesca Gorini, Susanna Ambrosio, Anna Noviello, Giovanni Scala, Barbara Majello iD, Stefano Amente iD

Cells · 2025

DOI: 10.3390/cells14020112 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2025. Verfasst von Anna Piscone und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine and Medical Biotechnologies, University of Naples 'Federico II', 80131 Naples, Italy. Hauptthemen laut MEDLINE: DNA Repair, Neoplasms, 8-Hydroxy-2'-Deoxyguanosine, Antineoplastic Agents. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Naples Federico II, National Center for Gene Therapy and Drugs, AIRC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genomic integrity is critical for cellular homeostasis, preventing the accumulation of mutations that can drive diseases such as cancer. Among the mechanisms safeguarding genomic stability, the Base Excision Repair (BER) pathway plays a pivotal role in counteracting oxidative DNA damage caused by reactive oxygen species. Central to this pathway are enzymes like 8-oxoguanine glycosylase 1 (OGG1), which recognize and excise 8-oxo-7,8-dihydro-2′-deoxyguanosine (8-oxodG) lesions, thereby initiating a series of repair processes that restore DNA integrity. BER inhibitors have recently been identified as a promising approach in cancer therapy, increasing the sensitivity of cancer cells to radiotherapy and chemotherapy. By exploiting tumor-specific DNA repair dependencies and synthetic lethal interactions, these inhibitors could be used to selectively target cancer cells while sparing normal cells. This review provides a robust reference for scientific researchers, offering an updated perspective on small-molecule inhibitors targeting the 8-oxodG-BER pathway and highlighting their potential role in expanding cancer treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA RepairNeoplasms8-Hydroxy-2'-DeoxyguanosineAntineoplastic AgentsHumansDNA GlycosylasesAnimalsDNA DamageExcision Repair

Stichwörter der Autor:innen

8-oxodGBERcancer therapy

Substanzen

8-Hydroxy-2'-DeoxyguanosineDNA GlycosylasesAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Molecular Medicine and Medical Biotechnologies, University of Naples 'Federico II', 80131 Naples, Italy.
  • Department of Biology, University of Naples 'Federico II', 80138 Naples, Italy.

ORCID-Profile: Barbara Majello, Stefano Amente

Förderung

  • University of Naples Federico II
  • National Center for Gene Therapy and Drugs
  • AIRC
  • Next Generation EU

Zitieren

APA

Piscone, A., Gorini, F., Ambrosio, S., Noviello, A., Scala, G., Majello, B., & Amente, S. (2025). Targeting the 8-oxodG Base Excision Repair Pathway for Cancer Therapy. Cells. https://doi.org/10.3390/cells14020112

Vancouver

Piscone A, Gorini F, Ambrosio S, Noviello A, Scala G, Majello B, et al. Targeting the 8-oxodG Base Excision Repair Pathway for Cancer Therapy. Cells. 2025. doi:10.3390/cells14020112

BibTeX
@article{Piscone2025,
  author = {Piscone, Anna and Gorini, Francesca and Ambrosio, Susanna and Noviello, Anna and Scala, Giovanni and Majello, Barbara and Amente, Stefano},
  title = {Targeting the 8-oxodG Base Excision Repair Pathway for Cancer Therapy},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14020112}
}
Kostenlos starten →